US Stock MarketDetailed Quotes

EDIT Editas Medicine

Watchlist
  • 5.210
  • -0.160-2.98%
Close Apr 30 16:00 ET
  • 5.300
  • +0.090+1.73%
Pre 09:05 ET
428.44MMarket Cap-2579P/E (TTM)

Editas Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-6.15%323.11M
-6.15%323.11M
-16.68%349.62M
-4.55%431.97M
-34.79%318.44M
-31.12%344.27M
-31.12%344.27M
-24.78%419.62M
-25.88%452.56M
-21.90%488.36M
-Cash and cash equivalents
-12.63%123.65M
-12.63%123.65M
-60.83%82.54M
30.35%220.82M
-38.82%129.02M
-30.46%141.52M
-30.46%141.52M
-18.92%210.7M
-49.86%169.4M
-40.58%210.88M
-Short-term investments
-1.62%199.46M
-1.62%199.46M
27.84%267.08M
-25.43%211.15M
-31.74%189.42M
-31.58%202.75M
-31.58%202.75M
-29.88%208.91M
3.83%283.16M
2.61%277.48M
Receivables
98.00%10.19M
98.00%10.19M
1,918.33%2.42M
220.62%2.29M
-82.35%242K
1,826.97%5.15M
1,826.97%5.15M
-52.19%120K
115.41%713K
104.02%1.37M
-Accounts receivable
98.00%10.19M
98.00%10.19M
1,918.33%2.42M
220.62%2.29M
-82.35%242K
1,826.97%5.15M
1,826.97%5.15M
-52.19%120K
115.41%713K
104.02%1.37M
Other current assets
2.67%7.53M
2.67%7.53M
-4.76%6.56M
-17.05%6.72M
-20.84%5.78M
1.90%7.34M
1.90%7.34M
-27.57%6.89M
49.89%8.11M
15.64%7.3M
Total current assets
-4.46%340.83M
-4.46%340.83M
-15.95%358.6M
-4.42%440.98M
-34.72%324.46M
-29.68%356.75M
-29.68%356.75M
-24.84%426.63M
-25.14%461.38M
-21.40%497.03M
Non current assets
Net PPE
-22.81%45.71M
-22.81%45.71M
14.38%43.5M
29.28%47.66M
21.71%49.56M
36.79%59.22M
36.79%59.22M
-12.45%38.03M
-18.49%36.86M
-6.19%40.72M
-Gross PPE
-10.86%71.97M
-10.86%71.97M
17.81%68.5M
28.31%71.15M
23.77%71.51M
37.32%80.74M
37.32%80.74M
1.17%58.15M
-5.05%55.45M
4.32%57.78M
-Accumulated depreciation
-21.99%-26.26M
-21.99%-26.26M
-24.29%-25.01M
-26.38%-23.49M
-28.69%-21.96M
-38.81%-21.53M
-38.81%-21.53M
-43.27%-20.12M
-41.07%-18.59M
-42.34%-17.06M
Investments and advances
11.74%104.02M
11.74%104.02M
64.50%96.8M
-35.97%48.07M
6.78%83.34M
-22.47%93.1M
-22.47%93.1M
-40.68%58.84M
-14.30%75.06M
-20.27%78.05M
Other non current assets
63.49%8.59M
63.49%8.59M
-23.57%5.76M
-30.24%5.25M
-7.70%6.75M
-22.87%5.25M
-22.87%5.25M
11.05%7.53M
11.06%7.53M
9.39%7.32M
Total non current assets
0.48%158.32M
0.48%158.32M
39.89%146.05M
-15.47%100.98M
10.76%139.65M
-7.41%157.57M
-7.41%157.57M
-30.13%104.4M
-14.42%119.46M
-14.80%126.08M
Total assets
-2.95%499.15M
-2.95%499.15M
-4.97%504.65M
-6.69%541.95M
-25.52%464.11M
-24.08%514.32M
-24.08%514.32M
-25.94%531.03M
-23.16%580.83M
-20.14%623.11M
Liabilities
Current liabilities
Payables
-13.06%8.27M
-13.06%8.27M
52.30%10.41M
30.75%8.07M
92.78%9.05M
88.34%9.51M
88.34%9.51M
100.94%6.84M
39.73%6.17M
-47.33%4.69M
-accounts payable
-13.06%8.27M
-13.06%8.27M
52.30%10.41M
30.75%8.07M
92.78%9.05M
88.34%9.51M
88.34%9.51M
100.94%6.84M
39.73%6.17M
-47.33%4.69M
Current accrued expenses
10.05%23.28M
10.05%23.28M
110.13%20.74M
51.19%21.48M
150.87%25.6M
110.86%21.16M
110.86%21.16M
99.98%9.87M
8.63%14.21M
-4.55%10.21M
Current debt and capital lease obligation
9.76%12.16M
9.76%12.16M
-19.04%9.69M
1.80%10.33M
-18.41%8.33M
7.50%11.08M
7.50%11.08M
16.66%11.97M
13.07%10.15M
40.50%10.21M
-Current capital lease obligation
9.76%12.16M
9.76%12.16M
-19.04%9.69M
1.80%10.33M
-18.41%8.33M
7.50%11.08M
7.50%11.08M
16.66%11.97M
13.07%10.15M
40.50%10.21M
Current deferred liabilities
0.00%8.22M
0.00%8.22M
94.76%8.22M
--8.22M
41.33%8.22M
-27.46%8.22M
-27.46%8.22M
-81.38%4.22M
--0
-82.21%5.82M
Current liabilities
5.17%63.22M
5.17%63.22M
38.58%58.6M
49.67%54.51M
56.58%57.16M
28.21%60.11M
28.21%60.11M
-16.93%42.29M
-44.83%36.42M
-42.97%36.5M
Non current liabilities
Long term debt and capital lease obligation
-25.84%24.37M
-25.84%24.37M
167.13%24.92M
165.64%26.86M
122.35%28.81M
104.52%32.86M
104.52%32.86M
-49.39%9.33M
-52.50%10.11M
-40.07%12.96M
-Long term capital lease obligation
-25.84%24.37M
-25.84%24.37M
167.13%24.92M
165.64%26.86M
122.35%28.81M
104.52%32.86M
104.52%32.86M
-49.39%9.33M
-52.50%10.11M
-40.07%12.96M
Non current deferred liabilities
0.00%60.67M
0.00%60.67M
-6.19%60.67M
-11.93%60.67M
-0.36%60.67M
-0.36%60.67M
-0.36%60.67M
6.21%64.67M
24.75%68.89M
7.45%60.89M
Other non current liabilities
--1.8M
--1.8M
----
----
----
----
----
----
----
----
Total non current liabilities
-7.15%86.84M
-7.15%86.84M
15.66%85.59M
10.79%87.52M
21.17%89.48M
21.54%93.53M
21.54%93.53M
-6.71%74M
3.26%79M
-5.68%73.85M
Total liabilities
-2.33%150.06M
-2.33%150.06M
24.00%144.19M
23.06%142.04M
32.88%146.63M
24.06%153.64M
24.06%153.64M
-10.71%116.28M
-19.02%115.42M
-22.45%110.35M
Shareholders'equity
Share capital
14.29%8K
14.29%8K
14.29%8K
14.29%8K
0.00%7K
0.00%7K
0.00%7K
0.00%7K
0.00%7K
0.00%7K
-common stock
14.29%8K
14.29%8K
14.29%8K
14.29%8K
0.00%7K
0.00%7K
0.00%7K
0.00%7K
0.00%7K
0.00%7K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-14.21%-1.23B
-14.21%-1.23B
-19.17%-1.21B
-21.40%-1.17B
-24.11%-1.13B
-25.70%-1.08B
-25.70%-1.08B
-24.64%-1.02B
-23.74%-961.67M
-25.80%-908.21M
Paid-in capital
9.56%1.58B
9.56%1.58B
9.60%1.57B
9.73%1.57B
1.65%1.45B
2.17%1.44B
2.17%1.44B
2.37%1.44B
2.87%1.43B
4.67%1.42B
Gains losses not affecting retained earnings
105.50%198K
105.50%198K
66.16%-1.45M
32.54%-2.29M
9.17%-2.28M
-630.43%-3.6M
-630.43%-3.6M
-6,604.69%-4.29M
-4,670.42%-3.39M
-3,336.99%-2.51M
Total stockholders'equity
-3.21%349.1M
-3.21%349.1M
-13.09%360.46M
-14.07%399.92M
-38.09%317.47M
-34.85%360.68M
-34.85%360.68M
-29.32%414.75M
-24.12%465.41M
-19.63%512.76M
Total equity
-3.21%349.1M
-3.21%349.1M
-13.09%360.46M
-14.07%399.92M
-38.09%317.47M
-34.85%360.68M
-34.85%360.68M
-29.32%414.75M
-24.12%465.41M
-19.63%512.76M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -6.15%323.11M-6.15%323.11M-16.68%349.62M-4.55%431.97M-34.79%318.44M-31.12%344.27M-31.12%344.27M-24.78%419.62M-25.88%452.56M-21.90%488.36M
-Cash and cash equivalents -12.63%123.65M-12.63%123.65M-60.83%82.54M30.35%220.82M-38.82%129.02M-30.46%141.52M-30.46%141.52M-18.92%210.7M-49.86%169.4M-40.58%210.88M
-Short-term investments -1.62%199.46M-1.62%199.46M27.84%267.08M-25.43%211.15M-31.74%189.42M-31.58%202.75M-31.58%202.75M-29.88%208.91M3.83%283.16M2.61%277.48M
Receivables 98.00%10.19M98.00%10.19M1,918.33%2.42M220.62%2.29M-82.35%242K1,826.97%5.15M1,826.97%5.15M-52.19%120K115.41%713K104.02%1.37M
-Accounts receivable 98.00%10.19M98.00%10.19M1,918.33%2.42M220.62%2.29M-82.35%242K1,826.97%5.15M1,826.97%5.15M-52.19%120K115.41%713K104.02%1.37M
Other current assets 2.67%7.53M2.67%7.53M-4.76%6.56M-17.05%6.72M-20.84%5.78M1.90%7.34M1.90%7.34M-27.57%6.89M49.89%8.11M15.64%7.3M
Total current assets -4.46%340.83M-4.46%340.83M-15.95%358.6M-4.42%440.98M-34.72%324.46M-29.68%356.75M-29.68%356.75M-24.84%426.63M-25.14%461.38M-21.40%497.03M
Non current assets
Net PPE -22.81%45.71M-22.81%45.71M14.38%43.5M29.28%47.66M21.71%49.56M36.79%59.22M36.79%59.22M-12.45%38.03M-18.49%36.86M-6.19%40.72M
-Gross PPE -10.86%71.97M-10.86%71.97M17.81%68.5M28.31%71.15M23.77%71.51M37.32%80.74M37.32%80.74M1.17%58.15M-5.05%55.45M4.32%57.78M
-Accumulated depreciation -21.99%-26.26M-21.99%-26.26M-24.29%-25.01M-26.38%-23.49M-28.69%-21.96M-38.81%-21.53M-38.81%-21.53M-43.27%-20.12M-41.07%-18.59M-42.34%-17.06M
Investments and advances 11.74%104.02M11.74%104.02M64.50%96.8M-35.97%48.07M6.78%83.34M-22.47%93.1M-22.47%93.1M-40.68%58.84M-14.30%75.06M-20.27%78.05M
Other non current assets 63.49%8.59M63.49%8.59M-23.57%5.76M-30.24%5.25M-7.70%6.75M-22.87%5.25M-22.87%5.25M11.05%7.53M11.06%7.53M9.39%7.32M
Total non current assets 0.48%158.32M0.48%158.32M39.89%146.05M-15.47%100.98M10.76%139.65M-7.41%157.57M-7.41%157.57M-30.13%104.4M-14.42%119.46M-14.80%126.08M
Total assets -2.95%499.15M-2.95%499.15M-4.97%504.65M-6.69%541.95M-25.52%464.11M-24.08%514.32M-24.08%514.32M-25.94%531.03M-23.16%580.83M-20.14%623.11M
Liabilities
Current liabilities
Payables -13.06%8.27M-13.06%8.27M52.30%10.41M30.75%8.07M92.78%9.05M88.34%9.51M88.34%9.51M100.94%6.84M39.73%6.17M-47.33%4.69M
-accounts payable -13.06%8.27M-13.06%8.27M52.30%10.41M30.75%8.07M92.78%9.05M88.34%9.51M88.34%9.51M100.94%6.84M39.73%6.17M-47.33%4.69M
Current accrued expenses 10.05%23.28M10.05%23.28M110.13%20.74M51.19%21.48M150.87%25.6M110.86%21.16M110.86%21.16M99.98%9.87M8.63%14.21M-4.55%10.21M
Current debt and capital lease obligation 9.76%12.16M9.76%12.16M-19.04%9.69M1.80%10.33M-18.41%8.33M7.50%11.08M7.50%11.08M16.66%11.97M13.07%10.15M40.50%10.21M
-Current capital lease obligation 9.76%12.16M9.76%12.16M-19.04%9.69M1.80%10.33M-18.41%8.33M7.50%11.08M7.50%11.08M16.66%11.97M13.07%10.15M40.50%10.21M
Current deferred liabilities 0.00%8.22M0.00%8.22M94.76%8.22M--8.22M41.33%8.22M-27.46%8.22M-27.46%8.22M-81.38%4.22M--0-82.21%5.82M
Current liabilities 5.17%63.22M5.17%63.22M38.58%58.6M49.67%54.51M56.58%57.16M28.21%60.11M28.21%60.11M-16.93%42.29M-44.83%36.42M-42.97%36.5M
Non current liabilities
Long term debt and capital lease obligation -25.84%24.37M-25.84%24.37M167.13%24.92M165.64%26.86M122.35%28.81M104.52%32.86M104.52%32.86M-49.39%9.33M-52.50%10.11M-40.07%12.96M
-Long term capital lease obligation -25.84%24.37M-25.84%24.37M167.13%24.92M165.64%26.86M122.35%28.81M104.52%32.86M104.52%32.86M-49.39%9.33M-52.50%10.11M-40.07%12.96M
Non current deferred liabilities 0.00%60.67M0.00%60.67M-6.19%60.67M-11.93%60.67M-0.36%60.67M-0.36%60.67M-0.36%60.67M6.21%64.67M24.75%68.89M7.45%60.89M
Other non current liabilities --1.8M--1.8M--------------------------------
Total non current liabilities -7.15%86.84M-7.15%86.84M15.66%85.59M10.79%87.52M21.17%89.48M21.54%93.53M21.54%93.53M-6.71%74M3.26%79M-5.68%73.85M
Total liabilities -2.33%150.06M-2.33%150.06M24.00%144.19M23.06%142.04M32.88%146.63M24.06%153.64M24.06%153.64M-10.71%116.28M-19.02%115.42M-22.45%110.35M
Shareholders'equity
Share capital 14.29%8K14.29%8K14.29%8K14.29%8K0.00%7K0.00%7K0.00%7K0.00%7K0.00%7K0.00%7K
-common stock 14.29%8K14.29%8K14.29%8K14.29%8K0.00%7K0.00%7K0.00%7K0.00%7K0.00%7K0.00%7K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -14.21%-1.23B-14.21%-1.23B-19.17%-1.21B-21.40%-1.17B-24.11%-1.13B-25.70%-1.08B-25.70%-1.08B-24.64%-1.02B-23.74%-961.67M-25.80%-908.21M
Paid-in capital 9.56%1.58B9.56%1.58B9.60%1.57B9.73%1.57B1.65%1.45B2.17%1.44B2.17%1.44B2.37%1.44B2.87%1.43B4.67%1.42B
Gains losses not affecting retained earnings 105.50%198K105.50%198K66.16%-1.45M32.54%-2.29M9.17%-2.28M-630.43%-3.6M-630.43%-3.6M-6,604.69%-4.29M-4,670.42%-3.39M-3,336.99%-2.51M
Total stockholders'equity -3.21%349.1M-3.21%349.1M-13.09%360.46M-14.07%399.92M-38.09%317.47M-34.85%360.68M-34.85%360.68M-29.32%414.75M-24.12%465.41M-19.63%512.76M
Total equity -3.21%349.1M-3.21%349.1M-13.09%360.46M-14.07%399.92M-38.09%317.47M-34.85%360.68M-34.85%360.68M-29.32%414.75M-24.12%465.41M-19.63%512.76M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday-1.50%